Published in Circulation on January 01, 1992
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med (1998) 4.22
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med (1981) 3.30
Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol (1997) 2.84
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol (1998) 2.59
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation (1995) 2.45
ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27
Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J Biol Chem (1979) 2.23
Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation (1996) 2.18
Electrophysiology of the atrio-AV nodal inputs and exits in the normal dog heart: radiofrequency ablation using an epicardial approach. J Cardiovasc Electrophysiol (1997) 2.10
Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation (1996) 2.08
Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation (1983) 2.05
Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter. Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation (1996) 2.04
Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system. J Cardiovasc Electrophysiol (2001) 1.99
The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol (1998) 1.95
Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation (1996) 1.94
Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med (1999) 1.85
Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation (1994) 1.81
The evaluation and management of bradycardia. N Engl J Med (2000) 1.79
Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation (2000) 1.74
Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation (2001) 1.73
Transseptal left heart catheterization for cardiac ablation procedures. J Interv Card Electrophysiol (2001) 1.61
Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol (1986) 1.56
Congestive heart failure with normal systolic function. Am J Cardiol (1984) 1.55
Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation (1978) 1.54
Elucidating the mechanisms of atrial flutter cycle length variability using power spectral analysis techniques. Circulation (1996) 1.52
Optimal cardiac pacing after heart transplantation. Pacing Clin Electrophysiol (1999) 1.50
Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol (1989) 1.48
Catheter ablation of macroreentrant atrial tachycardia in patients following atriotomy. Eur Heart J (2002) 1.48
Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation (1989) 1.47
Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation (1997) 1.46
Prolonged loss of consciousness and elevated porphyrins following propofol administrations. Anesthesiology (1998) 1.46
Catheter reuse: boon or boondoggle? Pacing Clin Electrophysiol (1998) 1.46
Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol (1982) 1.45
The management of atrial fibrillation. Am J Med (1996) 1.45
Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol (1998) 1.44
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function. Am J Med (1985) 1.44
Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol (2001) 1.44
Critical atrial site for ablation of pacing-induced atrial fibrillation in the normal dog heart. J Cardiovasc Electrophysiol (1997) 1.44
Adenosine and verapamil-sensitive ventricular tachycardia originating from the left ventricle: radiofrequency catheter ablation. Pacing Clin Electrophysiol (1992) 1.44
Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation (1979) 1.43
Current role of catheter ablative procedures in patients with cardiac arrhythmias. A report for health professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation (1991) 1.42
Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol (1983) 1.42
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation (1986) 1.41
Multicenter study of principles-based waveforms for external defibrillation. Ann Emerg Med (2001) 1.41
Hepatic mitochondrial function in ketogenic states. Diabetes, starvation, and after growth hormone administration. J Clin Invest (1975) 1.40
Management of atrial fibrillation: simplicity surrounded by controversy. Ann Intern Med (1997) 1.39
NASPE expert consensus statement: physician workforce in cardiac electrophysiology and pacing. NASPE task force, Washington, D.C. Pacing Clin Electrophysiol (1998) 1.39
Regional wall motion analysis predicts survival and functional outcome after subendocardial resection in patients with prior anterior myocardial infarction. Circulation (1993) 1.38
The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias. Am Heart J (1989) 1.38
Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med (1980) 1.36
Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation (1978) 1.35
The differential diagnosis of acute pericarditis from the normal variant: new electrocardiographic criteria. Circulation (1982) 1.34
Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. Circulation (1998) 1.31
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation (1978) 1.28
Electrical conduction between the right atrium and the left atrium via the musculature of the coronary sinus. Circulation (1998) 1.27
Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia. N Engl J Med (1980) 1.26
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia. J Am Coll Cardiol (1987) 1.24
Effects of dispersive electrode position and surface area on electrical parameters and temperature during radiofrequency catheter ablation. Am J Cardiol (1996) 1.22
Basic aspects of radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1994) 1.22
Reversing the direction of paced ventricular and atrial wavefronts reveals an oblique course in accessory AV pathways and improves localization for catheter ablation. Circulation (2001) 1.21
Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc (2000) 1.21
Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemia. Pacing Clin Electrophysiol (2001) 1.20
Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation (2000) 1.19
Recurrent sustained ventricular tachycardia. 2. Endocardial mapping. Circulation (1978) 1.18
A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J (1999) 1.18
Valsalva's maneuver revisited: a quantitative method yielding insights into human autonomic control. Am J Physiol (1996) 1.18
Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest (1973) 1.16
Recurrent sustained ventricular tachycardia. 4. Pleomorphism. Circulation (1979) 1.16
Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group. Am J Cardiol (1992) 1.16
Diagnosis of acute myocardial infarction in the emergency room: a prospective assessment of clinical decision making and the usefulness of immediate cardiac enzyme determination. J Community Health (1979) 1.15
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol (1984) 1.14
Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med (1982) 1.14
Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias. JAMA (1986) 1.13
Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Circulation (1981) 1.13
Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates. Circulation (1983) 1.13
Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med (1983) 1.11
Relation between late potentials on the body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia. Am J Cardiol (1983) 1.11
The pacemaker syndrome -- a matter of definition. Am J Cardiol (1997) 1.10
Catheter ablation of atrioventricular junction using radiofrequency current in 17 patients. Comparison of standard and large-tip catheter electrodes. Circulation (1991) 1.10
Anatomic substrate for idiopathic left ventricular tachycardia. Circulation (1996) 1.09
The Wolff-Parkinson-White syndrome: pharmacologic effects of procaine amide. Am Heart J (1975) 1.09
Influence of autothreshold sensing and sinus rate on mode switching algorithm behavior. Pacing Clin Electrophysiol (2000) 1.09
Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up. J Am Coll Cardiol (1990) 1.08
Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia. Circulation (1987) 1.08